Pregled bibliografske jedinice broj: 1268060
Unusual hair colour pattern following dissecting folliculitis treatment with isotretinoin
Unusual hair colour pattern following dissecting folliculitis treatment with isotretinoin // Pediatric Dermatology 2023, 40(S2)
Málaga, Španjolska, 2023. str. 77-77 doi:10.1111/pde.15301 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1268060 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Unusual hair colour pattern following
dissecting
folliculitis treatment with
isotretinoin
Autori
Ožanić Bulić, Suzana ; Pustišek, Nives ; Ulamec, Monika ; Brenner, Eva ; Bulić, Luka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Pediatric Dermatology 2023, 40(S2)
/ - , 2023, 77-77
Skup
22nd European Society for Pediatric Dermatology Annual Meeting
Mjesto i datum
Málaga, Španjolska, 04.05.2023. - 06.05.2023
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Dissecting folliculitis ; Isotretinoin ; Pigmentary hair changes
Sažetak
Objectives: Dissecting folliculitis (DF) of the scalp is a chronic, suppurative scalp disease on the background of follicular dysfunction, and an aberrant cutaneous immune response to commensal bacteria resulting in extensive scarring and irreversible alopecia. DF can exist as an isolated disease or in the form of acne tetrad sharing similar pathogenesis and histology with acne. DF has been successfully treated with oral tetracyclines and isotretinoin. Method: We present a 13-year-old male patient with DF. Extensive laboratory work-up including skin swabs was normal. On examination, multiple slightly erythematous to skin coloured round nodules measuring up to 30mm in diameter with overlying alopecia were observed in the scalp. Clinical diagnosis was confirmed by skin biopsy. Results: The histology showed unremarkable epidermis, extensive granulomatous inflammation in the subcutis, and small perifollicular and periadnexal epitheloid granulomas consisting of histiocytes surrounded by lymphocytes in the dermis. Special staining, APAS, Giemsa, Gomori and immunohistochemistry panel CK-PAN, CD68, S-100, CD1a were negative. Treatment with doxycycline failed to improve the lesions, therefore isotretinoin 0.5 mg/kg/day was introduced with resolution of inflammatory lesions and complete regrowth of significantly darker lesional hair compared to patient's natural shade of brown. Discussion: Pigmentary hair changes have been observed following chemotherapy, molecular targeted therapies, immunotherapies, radiotherapy, stem cell transplant and endocrine therapies, nevertheless the underlying mechanisms are still incompletely understood. Retinoids are known to cause various hair disorders, and the increased and unusual hair follicle pigmentation like observed in our patient, could be a new class specific adverse-event.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Klinika za dječje bolesti
Profili:
Monika Ulamec
(autor)
Eva Brenner
(autor)
Luka Bulić
(autor)
Suzana Ožanić Bulić
(autor)
Nives Pustišek
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE